×

 

  • About us
  • Company overview

Company overview

Aevisbio provides a scientific solution for the innovative drug development targeting incurable diseases such as inflammatory diseases, neurological disorders and drug resistant cancers.
Aevisbio has identified a novel series of Immunomodulatory imide drugs (IMiDs), exhibit multiple biological effects providing diverse drug development platforms such as TArgeted Proteolysis Inducer (TAPI).